From hydroxychloroquine to ivermectin: how unproven "cures" can go viral
Clin Microbiol Infect
.
2022 Apr;28(4):472-474.
doi: 10.1016/j.cmi.2022.01.008.
Epub 2022 Feb 3.
Authors
Fabio Silvio Taccone
1
,
Maya Hites
2
,
Nicolas Dauby
3
Affiliations
1
Department of Intensive Care, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium. Electronic address:
[email protected]
.
2
Department of Infectious Disease, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
3
Department of Infectious Diseases, St. Pierre Hospital, Université Libre de Bruxelles, Brussels, Belgium.
PMID:
35124262
PMCID:
PMC8810517
DOI:
10.1016/j.cmi.2022.01.008
No abstract available
Keywords:
COVID-19; Effectiveness; Hydroxychloroquine; Infodemic; Ivermectin.
MeSH terms
COVID-19*
Humans
Hydroxychloroquine* / therapeutic use
Ivermectin / therapeutic use
SARS-CoV-2
Substances
Hydroxychloroquine
Ivermectin